TSX:GUD (Knight Therapeutics Inc.)

About GUD

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
  • Knight Therapeutics Inc. (TSX: GUD) Latest News

    Businessperson's Hand Putting Coin In Piggybank
    Dividend Stocks

    TFSA: 3 Super Stocks That Can Make You Rich

    Top healthcare stocks like Savaria Corporation (TSX:SIS) have huge potential, which is why TFSA investors should target them today.

    Read more »

    edit Woman in skates works on laptop
    Investing

    Top TSX Stocks Under $10

    Markets have been somewhat volatile to close out this month, so investors should target TSX stocks that are on the…

    Read more »

    Test tubes
    Coronavirus

    2 TSX Pharma Stocks That Can Make You a TFSA Millionaire

    Here's why you can buy shares of Viemed Healthcare and Knight Therapeutics right now!

    Read more »

    Test tubes
    Investing

    TFSA: 3 Healthcare Stocks That Can Make You Filthy Rich

    TFSA investors should be on the hunt for the kind of growth offered by healthcare stocks like Knight Therapeutics Inc.…

    Read more »

    Pills spilling out of a prescription pot
    Dividend Stocks

    TFSA Investors: 2 Healthcare Stocks to Buy in May

    It has been a wild 2020, but TFSA investors should target exciting healthcare stocks like Knight Therapeutics Inc. (TSX:GUD) to…

    Read more »

    A person suffering
    Investing

    TFSA Investors: 2 Growth Stocks I’m Buying If the Market Selloff Gets Worse

    During turbulent economic times, investors usually want to dial back risk and retreat to stable income vehicles. However, recent history…

    Read more »

    Pills spilling out of a prescription pot
    Investing

    Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!

    Does the genius of CEO Jonathan Goodman of Knight Therapeutics Inc. (TSX:GUD) come for free?

    Read more »

    Financial technology concept.
    Investing

    Growth Investors: This Stock Could Easily Turn $10,000 Into $100,000

    Jonathan Goodman and Knight Therapeutics Inc. (TSX:GUD) could be the market's next great growth story. Are you willing to let…

    Read more »

    Gold medal
    Investing

    Revealed: 5 Top Growth Picks From This Award-Winning Mutual Fund

    One of Canada's best mutual funds is investing in small-cap growth companies like Freshii Inc. (TSX:FRII), Aritzia Inc. (TSX:ATZ), and…

    Read more »

    Pills spilling out of a prescription pot
    Investing

    5 Reasons Why This Pharma Stock Is Poised for Takeoff

    Knight Therapeutics Inc. (TSX:GUD) has an effective low-risk strategy combined with one of the best balance sheets in the industry.

    Read more »

    The Motley Fool
    Investing

    Can Knight Therapeutics Inc. Repeat the Success of Paladin Labs?

    Knight Therapeutics Inc. (TSX:GUD) offers investors exposure to the lucrative specialty pharmaceutical market.

    Read more »